Breaking News Bar

Business News and Information

Aerie Pharma shares bounce 25 percent on 'blockbuster' glaucoma trial results

Duke University pharma spin-off Aerie Pharmaceuticals is one step closer to getting what it calls a “blockbuster” therapy into the hands of glaucoma sufferers...
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear